about
How to Deal with Interval-Censored Data Practically while Assessing the Progression-Free Survival: A Step-by-Step Guide Using SAS and R Software.A Rescue Strategy for Handling Unevaluable Patients in Simon's Two Stage Design.From prospective biobanking to precision medicine: BIO-RAIDs - an EU study protocol in cervical cancerTime-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapy.Late toxicities and outcomes of adjuvant radiotherapy combined with concurrent bevacizumab in patients with triple-negative non-metastatic breast cancer.Prediction of long-term cumulative incidences based on short-term parametric model for competing risks: application in early breast cancer.Long-term results of permanent implant prostate cancer brachytherapy: A single-institution study of 675 patients treated between 1999 and 2003.Salivary gland-sparing helical tomotherapy for head and neck cancer: Preserved salivary function on quantitative salivary gland scintigraphy after tomotherapy.Time-Dependent Prognostic Impact of Circulating Tumor Cells Detection in Non-Metastatic Breast Cancer: 70-Month Analysis of the REMAGUS02 Study.[Work ability in cancer patients: Six years assessment after diagnosis in a cohort of 153 workers].Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.Radiotherapy associated with concurrent bevacizumab in patients with non-metastatic breast cancer.The impact of single-nucleotide polymorphisms (SNPs) in OGG1 and XPC on the age at onset of Huntington disease.Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial.[Breast conserving surgery in locoregional treatment of breast carcinoma after Hodgkin lymphoma]The fibroblast growth factor receptor 1 (FGFR1), a marker of response to chemoradiotherapy in breast cancer?Preoperative radio-chemotherapy in early breast cancer patients: long-term results of a phase II trial[Prospective monocentric study of the toxicity and the efficacy of concurrent trastuzumab and radiotherapy]Precision medicine: lessons learned from the SHIVA trial - Authors' replyProgression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review
P50
Q31132826-14443090-5A83-48FE-BD5E-E7C09271DFDBQ35774468-582EEE06-2C2F-4414-9927-5070696AAC30Q35831356-98EF8A26-9FE5-4165-902D-443592D79AEEQ36286709-EC1E1562-629C-46B3-9BD6-6B79B9587F18Q36295427-26FB3451-A280-40A8-A211-84CF91ED5AD1Q39852804-49C3875F-0972-436A-BCB6-3879D2C837B8Q40693561-9A4AB847-4974-4196-914A-DCD4970DD21AQ40705825-749BB278-4476-40E9-818D-E42826FA91F0Q41094757-85D1D28D-3F20-4B56-A3A1-4724E407CAACQ41634326-52CFB23A-BCCB-446F-9576-C38750AAD2C8Q42428880-175F2C33-5400-4180-920D-053CB36FBE77Q42698279-7863D1FB-FA44-441E-8B06-58CA50E08FACQ45293964-0776E77A-2605-4D21-A526-EE13EE17E2EEQ50531001-20A205B6-0617-4082-9252-EB1B37789B97Q83461750-30EB0B2A-27D9-4A76-8898-151DC7A2336BQ83719518-02DF84D9-18D6-4F2E-B0BC-E0A3CEE18CF7Q84929376-F3E29541-F48C-4EBD-9C89-C160BD821E68Q86407488-3076BA56-F739-408E-947D-17CBC1254B21Q86928864-B697EF86-4868-4C66-A371-AF8C198C8C5DQ90665238-F9ACE3E6-3E8C-4A98-A245-86CF0D4465ED
P50
description
Forscher
@de
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
Lisa Belin
@ast
Lisa Belin
@en
Lisa Belin
@es
Lisa Belin
@nl
type
label
Lisa Belin
@ast
Lisa Belin
@en
Lisa Belin
@es
Lisa Belin
@nl
prefLabel
Lisa Belin
@ast
Lisa Belin
@en
Lisa Belin
@es
Lisa Belin
@nl
P106
P31
P496
0000-0002-7628-6629